[et_pb_section fb_built=”1″ module_class=”white” _builder_version=”4.4.1″ background_color=”#0095CE” background_image=”https://coalitionoc.org/wp-content/uploads/2020/03/noise-tile.png” background_size=”initial” background_repeat=”repeat” border_width_right=”20px” border_color_right=”#00B4FA” border_width_left=”20px” border_color_left=”#00B4FA” border_width_right_tablet=”0px” border_width_right_phone=”” border_width_right_last_edited=”on|phone” border_width_left_tablet=”0px” border_width_left_phone=”” border_width_left_last_edited=”on|tablet” global_colors_info=”{}”][et_pb_row _builder_version=”4.4.1″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.4.1″ custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_text _builder_version=”4.4.2″ global_colors_info=”{}”]
PROGRAMS & INITIATIVES
Medication-Assisted Treatment
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ specialty=”on” _builder_version=”4.4.2″ global_colors_info=”{}”][et_pb_column type=”3_4″ specialty_columns=”3″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” background_enable_image=”off” global_colors_info=”{}”]
Opioid-Involved Deaths in the United States and California
In the U.S. there were 93,331 drug overdose deaths reported in 2020.
- Opioids were involved in 69,710 overdose deaths in 2020- 75% of all overdose deaths.
- Synthetic opioids were involved in 57,550 overdose deaths- 62% of all overdose deaths.
In California, there were 5,363 opioid related drug overdose deaths in 2020. Of those, 3,857 or 72% were due to fentanyl overdose.
[/et_pb_text][/et_pb_column_inner][/et_pb_row_inner][et_pb_row_inner _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_accordion _builder_version=”4.14.7″ _module_preset=”default” toggle_text_color=”#0C71C3″ toggle_level=”h4″ hover_enabled=”0″ border_color_top=”#EDF000″ border_style_top=”double” global_colors_info=”{}” sticky_enabled=”0″][et_pb_accordion_item title=”MATCONNECT Program ” open=”on” _builder_version=”4.14.7″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
The purpose of the MATCONNECT Program is to:
- Provide a holistic and patient-centered approach integrating physical and behavioral health services for subtance use disorders.
- Implement or expand an evidence-based medication assisted treatment program that supports recovery and health improvement to CALOPTIMA members.
[/et_pb_accordion_item][et_pb_accordion_item title=”MATCONNECT Program Goals” _builder_version=”4.14.7″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” open=”off” sticky_enabled=”0″]
- Ensure providers and staff trained to provide care in clinics
- Develop and implement a culturally appropriate anti-sigma campaign.
- Establish a partnership with Orange County Health Care Agency (OCHCA) Drug Medi-Cal Delivery System for referrals.
- Provide management oversight for MAT program and patient care coordiation.
- To improve accessiblity through telemdicine services.
[/et_pb_accordion_item][et_pb_accordion_item title=”Advantages of MAT” _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}” open=”off”]
- Safe
- Cost-Effective
- Reduce the risk of overdose
- Increase treatment retention
- Improve social functioning
- Reduced Risk of Infectious Disease Transmission.
- Reduced Justice system involvement.
[/et_pb_accordion_item][et_pb_accordion_item title=”MAT Intake Process ” _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}” open=”off”]
- Patient schedules MAT appointment
- Can be telemedicine or in-person visit
- Induction can be in office or at home
- Patient takes first dose, waits 30 minutes
- If the patient is still experiencing symptoms, take additional doses as directed. Patient calls provider if still experiencing symptoms.
- Initial prescription is for seven days during the first month of treatment.
[/et_pb_accordion_item][et_pb_accordion_item title=”Role of the Coalition of Orange County Community Health Centers ” _builder_version=”4.14.7″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” open=”off” sticky_enabled=”0″]
The role of the Coalition of Orange County Community Health Centers is to:
- Provide training for clinics and providers
- Development of MAT Program Toolkit; policies and procedure templates
- Project ECHO consultations
If you’re interested in participating in the MATCONNECT Program please contact Jewel Loff, MATCONNECT Program Director at jloff@coalitionoc.org
[/et_pb_accordion_item][/et_pb_accordion][/et_pb_column_inner][/et_pb_row_inner][/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_code disabled_on=”on|on|off” _builder_version=”4.4.2″ global_colors_info=”{}”][sidebar_menu menu=’14’ title=’Programs & Initiatives’][/et_pb_code][/et_pb_column][/et_pb_section]
